MRI for the differential diagnosis of neurodegenerative parkinsonism in clinical practice

Parkinsonism and Related Disorders

Volumn 13, Issue SUPPL. 3, 2007, Pages

  Seppi, Klaus ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Atypical parkinsonism; Corticobasal degeneration (CBD); Differential diagnosis; Magnetic resonance imaging (MRI); Multiple system atrophy (MSA); Parkinson's disease (PD); Progressive supranuclear palsy (PSP)

Indexed keywords

ARTICLE; BASAL GANGLION; BRAIN ATROPHY; CLINICAL PRACTICE; DEGENERATIVE DISEASE; DIFFERENTIAL DIAGNOSIS; DIFFUSION WEIGHTED IMAGING; NEURODEGENERATIVE PARKINSONISM; NUCLEAR MAGNETIC RESONANCE IMAGING; OLFACTORY SYSTEM; PARKINSONISM; PRIORITY JOURNAL; PROGNOSIS; PROTON NUCLEAR MAGNETIC RESONANCE; QUANTITATIVE ANALYSIS; SUBSTANTIA NIGRA; VOLUMETRY;

DIAGNOSIS, DIFFERENTIAL; HUMANS; MAGNETIC RESONANCE IMAGING; NERVE DEGENERATION; PARKINSONIAN DISORDERS;

EID: 38949161170     PISSN: 13538020     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1353-8020(08)70038-5     Document Type: Article

References (48)

1. Litvan I., Bhatia K., Burn D., Goetz C., Lang A., McKeith I., et al. Movement Disorders Society Scientific Issues Committee report: SIC Task Force appraisal of clinical diagnostic criteria for Parkinsonian disorders. Mov Disord 18 (2003) 467-486
2. Heiss W., and Hilker R. The sensitivity of 18-fluorodopa positron emission tomography and magnetic resonance imaging in Parkinson's disease. Eur J Neurol 11 (2004) 5-12
3. Seppi K., and Schocke M. An update on conventional and advanced magnetic resonance imaging techniques in the differential diagnosis of neurodegenerative parkinsonism. Curr Opin Neurol 18 (2005) 370-375
4. Drayer B., Olanow W., Burger P., Johnson G., Herfkens R., and Riederer S. Parkinson plus syndrome: diagnosis using high field MR imaging of brain iron. Radiology 159 (1986) 493-498
5. Pastakia B., Polinsky R., Di Chiro G., Simmons J., Brown R., and Wener L. Multiple system atrophy (Shy-Drager syndrome): MR imaging. Radiology 159 (1986) 499-502
6. Brooks D. Morphological and functional imaging studies on the diagnosis and progression of Parkinson's disease. J Neurol 247 Suppl 2 (2000) II11-II18
7. Savoiardo M. Differential diagnosis of Parkinson's disease and atypical parkinsonian disorders by magnetic resonance imaging. Neurol Sci 24 Suppl 1 (2003) S35-S37
8. Josephs K., Tang-Wai D., Edland S., Knopman D., Dickson D., Parisi J., et al. Correlation between antemortem magnetic resonance imaging findings and pathologically confirmed corticobasal degeneration. Arch Neurol 61 (2004) 1881-1884
9. Schulz J., Skalej M., Wedekind D., Luft A., Abele M., Voigt K., et al. Magnetic resonance imaging-based volumetry differentiates idiopathic Parkinson's syndrome from multiple system atrophy and progressive supranuclear palsy. Ann Neurol 45 (1999) 65-74
10. Ghaemi M., Hilker R., Rudolf J., Sobesky J., and Heiss W. Differentiating multiple system atrophy from Parkinson's disease: contribution of striatal and midbrain MRI volumetry and multi-tracer PET imaging. J Neurol Neurosurg Psychiatry 73 (2002) 517-523
11. Cordato N., Pantelis C., Halliday G., Velakoulis D., Wood S., Stuart G., et al. Frontal atrophy correlates with behavioural changes in progressive supranuclear palsy. Brain 125 (2002) 789-800
12. Groschel K., Hauser T., Luft A., Patronas N., Dichgans J., Litvan I., et al. Magnetic resonance imaging-based volumetry differentiates progressive supranuclear palsy from corticobasal degeneration. Neuroimage 21 (2004) 714-724
13. Ashburner J., and Friston K. Voxel-based morphometry - the methods. Neuroimage 11 (2000) 805-821
14. Burton E., McKeith I., Burn D., Williams E., and O'Brien J. Cerebral atrophy in Parkinson's disease with and without dementia: a comparison with Alzheimer's disease, dementia with Lewy bodies and controls. Brain 127 (2004) 791-800
15. Nagano-Saito A., Washimi Y., Arahata Y., Kachi T., Lerch J., Evans A., et al. Cerebral atrophy and its relation to cognitive impairment in Parkinson disease. Neurology 64 (2005) 224-229
16. Summerfield C., Junque C., Tolosa E., Salgado-Pineda P., Gomez-Anson B., Marti M., et al. Structural brain changes in Parkinson disease with dementia: a voxel-based morphometry study. Arch Neurol 62 (2005) 281-285
17. Brenneis C., Seppi K., Schocke M., Muller J., Luginger E., Bosch S., et al. Voxel-based morphometry detects cortical atrophy in the Parkinson variant of multiple system atrophy. Mov Disord 18 (2003) 1132-1138
18. Specht K., Minnerop M., Muller-Hubenthal J., and Klockgether T. Voxel-based analysis of multiple-system atrophy of cerebellar type: complementary results by combining voxel-based morphometry and voxel-based relaxometry. Neuroimage 25 (2005) 287-293
19. Specht K., Minnerop M., Abele M., Reul J., Wullner U., and Klockgether T. In vivo voxel-based morphometry in multiple system atrophy of the cerebellar type. Arch Neurol 60 (2003) 1431-1435
20. Brenneis C., Seppi K., Schocke M., Benke T., Wenning G., and Poewe W. Voxel based morphometry reveals a distinct pattern of frontal atrophy in progressive supranuclear palsy. J Neurol Neurosurg Psychiatry 75 (2004) 246-249
21. Price S., Paviour D., Scahill R., Stevens J., Rossor M., Lees A., et al. Voxel-based morphometry detects patterns of atrophy that help differentiate progressive supranuclear palsy and Parkinson's disease. Neuroimage 23 (2004) 663-669
22. Brenneis C., Egger K., Scherfler C., Seppi K., Schocke M., Poewe W., et al. Progression of brain atrophy in multiple system atrophy. A longitudinal VBM study. J Neurol 254 (2007) 191-196
23. Oba H., Yagishita A., Terada H., Barkovich A., Kutomi K., Yamauchi T., et al. New and reliable MRI diagnosis for progressive supranuclear palsy. Neurology 64 12 (2005) 2050-2055
24. Nicoletti G., Fera F., Condino F., Auteri W., Gallo O., Pugliese P., et al. MR imaging of middle cerebellar peduncle width: differentiation of multiple system atrophy from Parkinson disease. Radiology 239 (2006) 825-830
25. Wolff S., and Balaban R. Magnetization transfer contrast (MTC) and tissue water proton relaxation in vivo. Magn Reson Med 10 (1989) 135-144
26. Van Buchem M., McGowan J., and Grossman R. Magnetization transfer histogram methodology: its clinical and neuropsychological correlates. Neurology 53 Suppl 3 (1999) S23-S28
27. Le Bihan D. Looking into the functional architecture of the brain with diffusion MRI. Nat Rev Neurosci 4 (2003) 469-480
28. Schocke M., Seppi K., Esterhammer R., Kremser C., Mair K., Czermak B., et al. Trace of diffusion tensor differentiates the Parkinson variant of multiple system atrophy and Parkinson's disease. Neuroimage 21 (2004) 1443-1451
29. Hanyu H., Asano T., Sakurai H., Takasaki M., Shindo H., and Abe K. Magnetisation transfer measurements of the subcortical grey and white matter in Parkinson's disease with and without dementia and in progressive supranuclear palsy. Neuroradiology 43 (2001) 542-546
30. Naka H., Imon Y., Ohshita T., Honjo K., Kitamura T., Miyachi T., et al. Magnetization transfer measurements of brain structures in patients with multiple system atrophy. Neuroimage 17 (2002) 1572-1578
31. Eckert T., Sailer M., Kaufmann J., Schrader C., Peschel T., Bodammer N., et al. Differentiation of idiopathic Parkinson's disease, multiple system atrophy, progressive supranuclear palsy, and healthy controls using magnetization transfer imaging. Neuroimage 21 (2004) 229-235
32. Yoshikawa K., Nakata Y., Yamada K., and Nakagawa M. Early pathological changes in the parkinsonian brain demonstrated by diffusion tensor MRI. J Neurol Neurosurg Psychiatry 75 (2004) 481-484
33. Scherfler C., Schocke M., Seppi K., Esterhammer R., Brenneis C., Jaschke W., et al. Voxel-wise analysis of diffusion weighted imaging reveals disruption of the olfactory tract in Parkinson's disease. Brain 129 (2006) 538-542
34. Katzenschlager R., and Lees A. Olfaction and Parkinson's syndromes: its role in differential diagnosis. Curr Opin Neurol 17 (2004) 417-423
35. Seppi K., Schocke M., Esterhammer R., Kremser C., Brenneis C., Mueller J., et al. Diffusion-weighted imaging discriminates progressive supranuclear palsy from PD, but not from the parkinson variant of multiple system atrophy. Neurology 60 (2003) 922-927
36. Schocke M., Seppi K., Esterhammer R., Kremser C., Jaschke W., Poewe W., et al. Diffusion-weighted MRI differentiates the Parkinson variant of multiple system atrophy from PD. Neurology 58 (2002) 575-580
37. Nicoletti G., Lodi R., Condino F., Tonon C., Fera F., Malucelli E., et al. Apparent diffusion coefficient measurements of the middle cerebellar peduncle differentiate the Parkinson variant of MSA from Parkinson's disease and progressive supranuclear palsy. Brain 129 (2006) 2679-2687
38. Ito M., Watanabe H., Kawai Y., Atsuta N., Tanaka F., Naganawa S., et al. Usefulness of combined fractional anisotropy and apparent diffusion coefficient values for detection of involvement in multiple system atrophy. J Neurol Neurosurg Psychiatry 78 (2007) 722-728
39. Kanazawa M., Shimohata T., Terajima K., Onodera O., Tanaka K., Tsuji S., et al. Quantitative evaluation of brainstem involvement in multiple system atrophy by diffusion-weighted MR imaging. J Neurol 251 (2004) 1121-1124
40. Seppi K., Schocke M., Donnemiller E., Esterhammer R., Kremser C., Scherfler C., et al. Comparison of diffusion-weighted imaging and [(123)I]IBZM-SPECT for the differentiation of patients with the Parkinson variant of multiple system atrophy from those with Parkinson's disease. Mov Disord 19 (2004) 1438-1445
41. Paviour D., Thornton J., Lees A., and Jager H. Diffusion-weighted magnetic resonance imaging differentiates Parkinsonian variant of multiple-system atrophy from progressive supranuclear palsy. Mov Disord 22 (2007) 68-74
42. Blain C., Barker G., Jarosz J., Coyle N., Landau S., Brown R., et al. Measuring brain stem and cerebellar damage in parkinsonian syndromes using diffusion tensor MRI. Neurology 67 (2006) 2199-2205
43. 1H NMR spectroscopy of individual human brain metabolites at moderate field strengths. Magn Reson Imaging 21 (2003) 1295-1302
44. Firbank M., Harrison R., and O'Brien J. A comprehensive review of proton magnetic resonance spectroscopy studies in dementia and Parkinson's disease. Dement Geriatr Cogn Disord 14 (2002) 64-76
45. Schocke M., Berger T., Felber S., Wolf C., Deisenhammer F., Kremser C., et al. Serial contrast-enhanced magnetic resonance imaging and spectroscopic imaging of acute multiple sclerosis lesions under high- dose methylprednisolone therapy. Neuroimage 20 (2003) 1253-1263
46. Davie C., Wenning G., Barker G., Tofts P., Kendall B., Quinn N., et al. Differentiation of multiple system atrophy from idiopathic Parkinson's disease using proton magnetic resonance spectroscopy. Ann Neurol 37 (1995) 204-210
47. Clarke C., and Lowry M. Systematic review of proton magnetic resonance spectroscopy of the striatum in parkinsonian syndromes. Eur J Neurol 8 (2001) 573-577
48. 1H-MR spectroscopy in multiple system atrophy: NAA/Cr reduction in pontine base as a valuable diagnostic marker. J Neurol Neurosurg Psychiatry 75 (2004) 103-109